Latest Insider Transactions at Acceleron Pharma Inc (XLRN)
This section provides a real-time view of insider transactions for Acceleron Pharma Inc (XLRN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of ACCELERON PHARMA INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of ACCELERON PHARMA INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 19
2021
|
Habib J Dable CEO and President |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
98,450
-100.0%
|
-
|
|
Nov 19
2021
|
Kevin F Mclaughlin SVP, CFO and Treasurer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
10,681
-100.0%
|
-
|
|
Nov 19
2021
|
Jay T. Backstrom EVP, Research and Development |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
21,233
-100.0%
|
-
|
|
Nov 19
2021
|
Sujay Kango EVP, Chief Commercial Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
18,509
-100.0%
|
-
|
|
Nov 19
2021
|
Adam M Veness SVP, General Counsel and Sec. |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
23,423
-100.0%
|
-
|
|
Nov 19
2021
|
Francois Nader Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
6,749
-100.0%
|
-
|
|
Nov 19
2021
|
Laura Hamill Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
474
-100.0%
|
-
|
|
Nov 19
2021
|
Terrence C Kearney Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
6,749
-100.0%
|
-
|
|
Nov 19
2021
|
Thomas A Mccourt Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
6,044
-100.0%
|
-
|
|
Nov 19
2021
|
Karen L. Smith Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
1,622
-100.0%
|
-
|
|
Nov 19
2021
|
Christopher Hite Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
930
-100.0%
|
-
|
|
Nov 19
2021
|
Kemal Malik Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
1,622
-100.0%
|
-
|
|
Nov 19
2021
|
Joseph S Zakrzewski Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
34,499
-100.0%
|
-
|
|
Nov 09
2021
|
Adam M Veness SVP, General Counsel and Sec. |
BUY
Exercise of conversion of derivative security
|
Direct |
4,500
+16.12%
|
$130,500
$29.37 P/Share
|
|
Sep 27
2021
|
Sujay Kango EVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-21.27%
|
$875,000
$175.0 P/Share
|
|
Sep 27
2021
|
Sujay Kango EVP, Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+17.54%
|
$200,000
$40.61 P/Share
|
|
Sep 24
2021
|
Kevin F Mclaughlin SVP, CFO and Treasurer |
SELL
Open market or private sale
|
Direct |
5,370
-33.46%
|
$859,200
$160.38 P/Share
|
|
Sep 24
2021
|
Kevin F Mclaughlin SVP, CFO and Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,370
+12.86%
|
$220,170
$41.13 P/Share
|
|
Sep 23
2021
|
Kevin F Mclaughlin SVP, CFO and Treasurer |
SELL
Open market or private sale
|
Direct |
19,630
-34.97%
|
$3,140,800
$160.76 P/Share
|
|
Sep 23
2021
|
Kevin F Mclaughlin SVP, CFO and Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct |
19,630
+21.77%
|
$726,310
$37.47 P/Share
|
|
Sep 21
2021
|
Sujay Kango EVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-21.27%
|
$750,000
$150.03 P/Share
|
|
Sep 21
2021
|
Sujay Kango EVP, Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+17.54%
|
$200,000
$40.61 P/Share
|
|
Sep 21
2021
|
Adam M Veness SVP, General Counsel and Sec. |
SELL
Open market or private sale
|
Direct |
6,650
-26.0%
|
$997,500
$150.05 P/Share
|
|
Sep 21
2021
|
Adam M Veness SVP, General Counsel and Sec. |
BUY
Exercise of conversion of derivative security
|
Direct |
6,650
+11.55%
|
$232,750
$35.69 P/Share
|
|
Sep 09
2021
|
Adam M Veness SVP, General Counsel and Sec. |
SELL
Open market or private sale
|
Direct |
1,407
-6.92%
|
$182,910
$130.0 P/Share
|
|
Sep 08
2021
|
Adam M Veness SVP, General Counsel and Sec. |
SELL
Open market or private sale
|
Direct |
6
-0.03%
|
$780
$130.0 P/Share
|
|
Sep 07
2021
|
Adam M Veness SVP, General Counsel and Sec. |
SELL
Payment of exercise price or tax liability
|
Direct |
587
-2.81%
|
$75,723
$129.36 P/Share
|
|
Jul 02
2021
|
Habib J Dable CEO and President |
SELL
Open market or private sale
|
Direct |
42,186
-10.86%
|
$5,357,622
$127.47 P/Share
|
|
Jul 02
2021
|
Habib J Dable CEO and President |
BUY
Exercise of conversion of derivative security
|
Direct |
42,186
+23.07%
|
$1,476,510
$35.04 P/Share
|
|
Jul 01
2021
|
Habib J Dable CEO and President |
SELL
Open market or private sale
|
Direct |
57,814
-8.71%
|
$7,284,564
$126.9 P/Share
|
|
Jul 01
2021
|
Habib J Dable CEO and President |
BUY
Exercise of conversion of derivative security
|
Direct |
57,814
+27.01%
|
$2,023,490
$35.04 P/Share
|
|
Jun 07
2021
|
Adam M Veness SVP, General Counsel and Sec. |
SELL
Payment of exercise price or tax liability
|
Direct |
108
-0.51%
|
$13,608
$126.69 P/Share
|
|
Apr 19
2021
|
Thomas A Mccourt Director |
SELL
Open market or private sale
|
Direct |
7,500
-17.42%
|
$892,500
$119.79 P/Share
|
|
Apr 19
2021
|
Thomas A Mccourt Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+35.64%
|
$300,000
$40.61 P/Share
|
|
Apr 05
2021
|
Karen L. Smith Director |
SELL
Open market or private sale
|
Direct |
11,864
-55.77%
|
$1,660,960
$140.64 P/Share
|
|
Apr 05
2021
|
Karen L. Smith Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,925
+20.54%
|
$383,775
$43.32 P/Share
|
|
Apr 05
2021
|
Joseph S Zakrzewski Director |
SELL
Open market or private sale
|
Direct |
10,000
-7.98%
|
$1,410,000
$141.29 P/Share
|
|
Apr 05
2021
|
Joseph S Zakrzewski Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+18.35%
|
$240,000
$24.11 P/Share
|
|
Apr 01
2021
|
Karen L. Smith Director |
SELL
Open market or private sale
|
Direct |
8,925
-22.79%
|
$1,213,800
$136.4 P/Share
|
|
Apr 01
2021
|
Karen L. Smith Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,925
+20.54%
|
$383,775
$43.32 P/Share
|
|
Apr 01
2021
|
Joseph S Zakrzewski Director |
SELL
Open market or private sale
|
Direct |
10,000
-6.01%
|
$1,340,000
$134.44 P/Share
|
|
Apr 01
2021
|
Joseph S Zakrzewski Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+18.35%
|
$240,000
$24.11 P/Share
|
|
Mar 02
2021
|
Sujay Kango EVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-5.49%
|
$680,000
$136.75 P/Share
|
|
Mar 02
2021
|
Sujay Kango EVP, Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+17.01%
|
$200,000
$40.61 P/Share
|
|
Feb 12
2021
|
Sujay Kango EVP, Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
887
-4.57%
|
$115,310
$130.87 P/Share
|
|
Jan 29
2021
|
Francois Nader Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,622
+19.38%
|
-
|
|
Jan 29
2021
|
Laura Hamill Director |
BUY
Grant, award, or other acquisition
|
Direct |
474
+50.0%
|
-
|
|
Jan 29
2021
|
Christopher Hite Director |
BUY
Grant, award, or other acquisition
|
Direct |
930
+50.0%
|
-
|
|
Jan 29
2021
|
Terrence C Kearney Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,622
+19.38%
|
-
|
|
Jan 29
2021
|
Kemal Malik Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,622
+50.0%
|
-
|